Koon Yew Yin 22 June 2020
![](data:image/svg+xml;charset=utf-8,<svg height="154" width="902" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
I refer to the above report, total issued shares is 1,300 million.
1st quarter revenue Rm 447 million, NP 71 million, EPS 5.42 sen.
Since the company has its own sale outlets in US and other countries, it can easily increase its selling price for gloves. Any price increase is pure profit.
It is quite safe to assume it can increase gradually 100% minus 30% tax = 70% by the end of the 4th quarter. That is 70% of Rm 447 million = Rm 313 million divided by 3 = Rm 104 million or 8 sen EPS in each quarter.
2nd quarter EPS 5.42 sen + 8 sen = 13.4 sen
3rd quarter EPS 13.4 sen + 8 sen = 21.4 sen
4th quarter EPS 21.4 sen + 8 sen = 29.4 sen
Total 70 sen
Assuming P/E 20 target price Rm 14
Assuming P/E 15 target price Rm 10.5
Useful information:
The World Health Organisation has just reported 150,000 new Covid 19 cases, the biggest number of Covid 19 cases in one single day. US has 2.356 million cases and 122,200 deaths and Brazil has 1.089 million cases and 50,600 deaths. Based on the continuous increase of cases in almost all the countries in the world, the pandemic is still spreading quietly rapidly. Many scientists predicted the pandemic will not be under control for at least another year.
It looks like the demand for gloves will continue to exceed supply. As a result, glove price will continue to increase and all the glove manufacturers are making more and more profit which should be reflected on their share prices.